Adenomyosis Treatment Market to Grow at 4.1% CAGR Between 2018 and 2023


Market Overview:
Adenomyosis is defined as a medical condition in which the inner lining of the uterus (also known as the endometrium) breaks through the muscle wall of the uterus (the myometrium). The treatment of this medical problem is called adenomyosis treatment. A new report on the global Adenomyosis Treatment Market, published by Market Research Future (MRFR), states that this market can visualize progress at 4.1% CAGR during the forecast period (2018-2023). In terms of value, the market can be worth USD 291.5 Mn by the end of the forecast period.
The biggest driver for the global adenomyosis treatment market growth is the global prevalence of adenomyosis. The increasing awareness about adenomyosis as well as its treatment is boosting the global adenomyosis treatment market by creating the demand, supply, and sales for new drugs and therapies, along with advanced medical technology-focused towards the adenomyosis. Hence, new opportunities are arising for market growth. During the forecast period, increased funding for research & development (R&D) to develop more advanced products (medical devices) is expected to reflect favorably on the market. However, the market in developing countries can face hurdles as many people are not aware of this medical problem.
Key Players
·         Bayer AG
·         Ferring B.V
·         Johnson & Johnson Consumer Inc
·         Merck KGaA
·         Novartis
·         Pfizer Inc
·         Speciality European Pharma
Market Segmentation
·         The global adenomyosis treatment market segmentation encompasses diagnosis, type, and treatment. MRFR’s take on the market marks various facets of the market in-depth.
·         The diagnosis-based segmentation of this market covers endometrial biopsy, magnetic resonance imaging (MRI), ultrasound, and others. The ultrasound segment has been sub-segmented into transabdominal ultrasound and endovaginal ultrasound which is also known as transvaginal ultrasound.
·         By type, the market includes adenomyoma, diffuse, focal, and others.
·         By treatment, the market covers anti-inflammatory drugs, hormone medications, and hysterectomy. The anti-inflammatory drugs segment has been sub-segmented into Advil, ibuprofen, Motrin ibuprofen (Motrin IB), and others.
Regional Segmentation
A geographical outlining of the global adenomyosis treatment market covers the Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA).
The Americas is the biggest regional market as North America alone has the potential of becoming a powerful regional market. Due to the advanced medical facilities being available in the USA North America is a larger regional market segment compared to South America. North America is the largest regional market segment due to the rapid adoption of new drugs and therapies. Continuous innovation on the technological front and heavy use of technology in the medical sector boost market in this region. USA and Canada are generating the maximum revenue in this region.
Europe is the second-largest regional market as many important market players are based in Europe. Due to the reasons the same as in The Americas, Western Europe is a bigger market compared to Eastern Europe. The major market share comes from France, Germany, Spain, Italy, and the UK.
The Asia Pacific region is an important regional market due to improving medical sector and stable technological progress. In this report, this regional market has been segmented into Asia and the Pacific. In Asia, the key country-specific markets are China, India, Japan, and South Korea. An observation of the remaining countries in Asia and the Pacific region featured in this report calculates the additional market revenue from some other countries.
In the MEA region, the market has been slow due to limited availability of advanced medical facilities. Countries focused in the report include Egypt, Saudi Arabia, and the UAE.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more